Susquehanna International Group
SGYP

Susquehanna International Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Susquehanna International Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-818,500
Closed -$93K – 10465
2018
Q4 		$93K Sell
818,500
-361,700
-31% -$237K ﹤0.01% 8253
2018
Q3 		$2.01M Sell
1,180,200
-158,400
-12% -$284K ﹤0.01% 3989
2018
Q2 		$2.33M Sell
1,338,600
-373,900
-22% -$646K ﹤0.01% 3761
2018
Q1 		$3.13M Sell
1,712,500
-405,500
-19% -$856K ﹤0.01% 3189
2017
Q4 		$4.72M Buy
2,118,000
+602,600
+40% +$1.5M ﹤0.01% 2597
2017
Q3 		$4.39M Buy
1,515,400
+139,000
+10% +$474K ﹤0.01% 2664
2017
Q2 		$6.13M Sell
1,376,400
-198,400
-13% -$818K ﹤0.01% 2173
2017
Q1 		$7.34M Buy
1,574,800
+1,013,100
+180% +$5.87M ﹤0.01% 1941
2016
Q4 		$3.42M Buy
561,700
+143,100
+34% +$748K ﹤0.01% 3018
2016
Q3 		$2.31M Sell
418,600
-49,900
-11% -$234K ﹤0.01% 3321
2016
Q2 		$1.78M Buy
468,500
+208,900
+80% +$708K ﹤0.01% 3775
2016
Q1 		$716K Sell
259,600
-245,100
-49% -$888K ﹤0.01% 5746
2015
Q4 		$2.86M Sell
504,700
-148,800
-23% -$907K ﹤0.01% 3368
2015
Q3 		$3.46M Buy
653,500
+101,300
+18% +$784K ﹤0.01% 3252
2015
Q2 		$4.58M Buy
552,200
+429,500
+350% +$2.08M ﹤0.01% 3058
2015
Q1 		$567K Buy
122,700
+95,100
+345% +$309K ﹤0.01% 6861
2014
Q4 		$84K Sell
27,600
-50,000
-64% -$148K ﹤0.01% 9245
2014
Q3 		$216K Sell
77,600
-77,200
-50% -$280K ﹤0.01% 8553
2014
Q2 		$630K Buy
154,800
+32,900
+27% +$140K ﹤0.01% 7035
2014
Q1 		$647K Buy
121,900
+82,557
+210% +$463K ﹤0.01% 6303
2013
Q4 		$218K Sell
39,343
-6,693
-15% -$28.9K ﹤0.01% 8114
2013
Q3 		$207K Sell
46,036
-26,161
-36% -$117K ﹤0.01% 7733
2013
Q2 		$308K Buy
+72,197
New +$363K ﹤0.01% 6765

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's SGYP Position: Q1 2019 in Review

Susquehanna International Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 1,236,697 shares — an estimated $141K sold.

Susquehanna International Group first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $31.9M in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Susquehanna International Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Susquehanna International Group sold 1,236,697 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $141K.
  • Susquehanna International Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
  • Susquehanna International Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $31.9M in Q4 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.